| Ovidrel (choriogonadotropin alfa) / EMD Serono |
NCT01851512: A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803 |
|
|
| Completed | 1 | 27 | RoW | T-R (Test-Reference drug), Drug: DA-3803 (Test drug), Drug: Ovidrel liquid injection (Referecne drug), R-T (Reference-Test drug) | Dong-A Pharmaceutical Co., Ltd. | Infertility, Induction of Ovulation | 08/10 | 04/11 | | |
ChiCTR-IIR-16010158: A Single-Dose Study to Compare the pharmacokinetic parameters of LZM003 (T) and Ovidrel(R) using a subcutaneous injection administration in Healthy Chinese Subjects |
|
|
| Recruiting | 1 | 48 | | LZM003 (T)-Ovidrel(R) ;Ovidrel(R)-LZM003 (T) | Chinese PLA General Hospital; Livzon Mabpharm Inc., Provide by sponsor | Bioequivalence | | | | |
NCT01422733: Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction |
|
|
| Withdrawn | 1 | 0 | US | Hydrocortisone, dexamethasone, Cosyntropin, Tetracosactide, rhCG, (Ovidrel) | University of Virginia | Hyperandrogenemia, Obesity, Polycystic Ovary Syndrome | 07/18 | 07/18 | | |
NCT05450900: Can Biotin Supplementation be Used to Mask hCG Abuse? |
|
|
| Completed | 1 | 10 | US | Choriogonadotropin Alpha, ovidrel, hCG, biotin, vitamin B7, Microcellulose filler, placebo, capsules | Sports Medicine Research and Testing Laboratory | Healthy | 02/23 | 02/23 | | |
NCT06599528: A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects |
|
|
| Not yet recruiting | 1 | 48 | RoW | T-R (Test-Reference drug), R-T (Reference-Test drug) | Suzhou Centergene Pharmaceuticals Co.,Ltd. | Assisted Reproductive Technology, Female Infertility | 06/26 | 12/26 | | |
NCT03905603: Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS |
|
|
| Recruiting | 1 | 144 | US | ACTH, Cosyntropin, rhCG, Ovidrel | University of Virginia | Polycystic Ovary Syndrome | 04/26 | 05/26 | | |
